Research programme: women's health therapeutics - Avion Pharmaceuticals

Drug Profile

Research programme: women's health therapeutics - Avion Pharmaceuticals

Alternative Names: Captisol®-enabled therapeutics - Avion Pharmaceuticals; Cyclodextrin-enabled therapeutics - Avion Pharmaceuticals

Latest Information Update: 22 Aug 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Avion Pharmaceuticals
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Female genital diseases

Most Recent Events

  • 15 Aug 2014 Early research in Gynaecological disorders in USA (Topical)
  • 15 Aug 2014 Early research in Gynaecological disorders in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top